Paul J Clancy Incyte Corp (INCY) insider trading activity

INCY Quotes by TradingView

Paul J Clancy is Director of INCYTE CORP. Currently has a direct ownership of 19,382 shares of INCY, which is worth approximately $1.35 Million. The most recent transaction as insider was on Sep 30, 2024, when has been sold 368 shares (Common Stock) at a price of $66.1 per share, resulting in proceeds of $24,324. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.4K
1.94% 3M change
29.47% 12M change
Total Value Held $1.35 Million

Paul J Clancy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2024
BUY
Grant, award, or other acquisition
$24,324 $66.1 p/Share
368 Added 1.86%
19,382 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
$24,187 $60.62 p/Share
399 Added 2.06%
19,014 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
2,830 Added 13.2%
18,615 Common Stock
Mar 28 2024
BUY
Grant, award, or other acquisition
$22,958 $56.97 p/Share
403 Added 2.49%
15,785 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$25,869 $62.79 p/Share
412 Added 2.61%
15,382 Common Stock
Sep 29 2023
BUY
Grant, award, or other acquisition
$21,894 $57.77 p/Share
379 Added 2.47%
14,970 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
$23,655 $62.25 p/Share
380 Added 2.54%
14,591 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
2,505 Added 14.99%
14,211 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
$22,981 $72.27 p/Share
318 Added 2.64%
11,706 Common Stock
Dec 30 2022
BUY
Grant, award, or other acquisition
$23,614 $80.32 p/Share
294 Added 2.52%
11,388 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
$22,591 $66.64 p/Share
339 Added 2.97%
11,094 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$24,386 $75.97 p/Share
321 Added 2.9%
10,755 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
2,144 Added 17.05%
10,434 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
$25,891 $79.42 p/Share
326 Added 3.78%
8,290 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$25,176 $73.4 p/Share
343 Added 4.13%
7,964 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
$22,078 $68.78 p/Share
321 Added 4.04%
7,621 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$23,809 $84.13 p/Share
283 Added 3.73%
7,300 Common Stock
May 26 2021
BUY
Grant, award, or other acquisition
-
1,923 Added 21.51%
7,017 Common Stock
Mar 31 2021
BUY
Grant, award, or other acquisition
$24,218 $81.27 p/Share
298 Added 5.53%
5,094 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
$24,441 $86.98 p/Share
281 Added 5.53%
4,796 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
$23,332 $89.74 p/Share
260 Added 5.45%
4,515 Common Stock

Also insider at

EXAS
EXACT SCIENCES CORP Healthcare
AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
Director
XLO
Xilio Therapeutics, Inc. Healthcare
PJC

Paul J Clancy

Director
Wilmington, DE

Track Institutional and Insider Activities on INCY

Follow INCYTE CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INCY shares.

Notify only if

Insider Trading

Get notified when an Incyte Corp insider buys or sells INCY shares.

Notify only if

News

Receive news related to INCYTE CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INCY